JPY 632.0
(-1.25%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 10.79 Million JPY | 5.87% |
2022 | 10.19 Million JPY | 3.18% |
2021 | 9.88 Million JPY | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | 6.76 Million JPY | -27.76% |
2024 Q1 | 9.36 Million JPY | -13.25% |
2023 FY | 10.79 Million JPY | 5.87% |
2023 Q4 | 10.79 Million JPY | 15.1% |
2023 Q3 | 9.37 Million JPY | 4.84% |
2023 Q2 | 8.94 Million JPY | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
KOHJIN BIO CO LTD | 683.01 Million JPY | 98.42% |
PRISM BioLab Co.,LTD | 17.92 Million JPY | 39.796% |
GNI Group Ltd. | 2.33 Billion JPY | 99.537% |
Linical Co., Ltd. | - JPY | -Infinity% |
Trans Genic Inc. | 2.22 Billion JPY | 99.515% |
MEDINET Co., Ltd. | 67.48 Million JPY | 84.004% |
Soiken Holdings Inc. | 1.12 Billion JPY | 99.037% |
Cytori Cell Research Institute, Inc. | 103.53 Million JPY | 89.574% |
AnGes, Inc. | 1.61 Billion JPY | 99.332% |
OncoTherapy Science, Inc. | 73.99 Million JPY | 85.413% |
Nxera Pharma Co., Ltd. | 2.9 Billion JPY | 99.628% |
Immuno-Biological Laboratories Co., Ltd. | 321.91 Million JPY | 96.647% |
NanoCarrier Co., Ltd. | 184 Thousand JPY | -5766.304% |
Carna Biosciences, Inc. | 140.14 Million JPY | 92.298% |
CanBas Co., Ltd. | 728 Thousand JPY | -1382.692% |
D. Western Therapeutics Institute, Inc. | 87.86 Million JPY | 87.715% |
RaQualia Pharma Inc. | 147.93 Million JPY | 92.704% |
Chiome Bioscience Inc. | 64.1 Million JPY | 83.163% |
Kidswell Bio Corporation | 875.65 Million JPY | 98.767% |
PeptiDream Inc. | 2.4 Billion JPY | 99.551% |
Oncolys BioPharma Inc. | 5.34 Million JPY | -102.059% |
Ribomic Inc. | 2.27 Million JPY | -374.67% |
SanBio Company Limited | - JPY | -Infinity% |
Healios K.K. | - JPY | -Infinity% |
BrightPath Biotherapeutics Co., Ltd. | 1.00 JPY | -1079399900.0% |
Kubota Pharmaceutical Holdings Co., Ltd. | 36 Million JPY | 70.017% |
Delta-Fly Pharma, Inc. | - JPY | -Infinity% |
StemRIM | 29 Million JPY | 62.779% |
CellSource Co., Ltd. | 305.92 Million JPY | 96.472% |
FunPep Company Limited | 25.54 Million JPY | 57.739% |
Kringle Pharma, Inc. | 364.05 Million JPY | 97.035% |
Stella Pharma Corporation | 1.11 Billion JPY | 99.033% |
TMS Co., Ltd. | 50.02 Million JPY | 78.423% |
Noile-Immune Biotech Inc. | 20.9 Million JPY | 48.357% |
Cuorips Inc. | 1.04 Million JPY | -934.899% |
Takara Bio Inc. | 11.85 Billion JPY | 99.909% |
ReproCELL Incorporated | 248.14 Million JPY | 95.65% |
PhoenixBio Co., Ltd. | 450.58 Million JPY | 97.604% |
StemCell Institute Inc. | 42.26 Million JPY | 74.459% |
Japan Tissue Engineering Co., Ltd. | 228.56 Million JPY | 95.277% |
CellSeed Inc. | 46.19 Million JPY | 76.632% |